| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/19/1997 | EP0758376A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 02/19/1997 | EP0491878B1 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/19/1997 | CN1143390A Method of synthesizing fluorescently labeled protein |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143374A Non-viral vector |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/19/1997 | CN1143116A New human erythropoietin |
| 02/19/1997 | CN1142973A Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases |
| 02/19/1997 | CN1142895A Fungicidal compounds and its use |
| 02/19/1997 | CN1034086C Heteropolysaccharide S-657 |
| 02/19/1997 | CN1034080C Preparing method for insulin analogs |
| 02/19/1997 | CN1034055C Monoclone antibody used for preparing medicine of therapeutic imflammation region |
| 02/18/1997 | US5604121 Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| 02/18/1997 | US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody |
| 02/18/1997 | US5604116 Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5604102 Detecting and monitoring a terminal fragment of the beta-amyloid precursor protein produced by beta-secretase cleavage; alzheimer's disease |
| 02/18/1997 | US5604094 Receptor-type phosphotyrosine phosphatase-β |
| 02/18/1997 | US5604092 Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein |
| 02/18/1997 | US5603931 Administering hybrid reagent comprising first portion having affinity for cellular target and second portion having affinity for bioactive molecule, which can be selectively released in response to change in ph |
| 02/13/1997 | WO1997005272A1 Glycoprotein from yeast |
| 02/13/1997 | WO1997005259A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
| 02/13/1997 | WO1997005256A2 Mammalian pro-hormone convertase |
| 02/13/1997 | WO1997005255A2 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | WO1997005253A2 Transketolase-related protein |
| 02/13/1997 | WO1997005252A2 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005240A1 Regulated autocrine growth of mammalian cells |
| 02/13/1997 | WO1997005170A2 Broad specificity antibodies |
| 02/13/1997 | WO1997005166A1 Transforming growth factor beta crystals |
| 02/13/1997 | WO1997005164A1 Papillomavirus polyprotein constructs |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | WO1996013583A3 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 02/13/1997 | CA2228727A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2227988A1 Mammalian pro-protein converting enzyme |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227599A1 Broad specificity antibodies |
| 02/13/1997 | CA2225551A1 Helper viruses for preparing recombinant viral vectors |
| 02/13/1997 | CA2200606A1 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/12/1997 | EP0757993A1 Preventive for circulatory diseases |
| 02/12/1997 | EP0757720A1 Trimerising polypeptides, their manufacture and use |
| 02/12/1997 | EP0757719A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
| 02/12/1997 | EP0757717A1 Papillomavirus vaccines |
| 02/12/1997 | EP0757696A1 Human sperm diagnostic |
| 02/12/1997 | EP0757689A1 Porphocyanine and cnc-expanded porphyrins |
| 02/12/1997 | EP0757557A1 Methods for inducing t cell tolerance to a tissue or organ graft |
| 02/12/1997 | EP0470184B1 Antibodies specific for cd4-binding domain of hiv |
| 02/12/1997 | CN1142855A Humanized antibodies and uses thereof |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142775A Preparation and use of immunoconjugates |
| 02/12/1997 | CN1142774A Vibrio cholerae 01(CVD111) and Non-01(CVD112 and CVD112RM) serogroup vaccine strains and methods of making same |
| 02/12/1997 | CN1142536A Bacillus-derived transglutaminase |
| 02/12/1997 | CN1142505A Anti-idiotypic antibodies which induce immune response against epidermal growth factor receptor |
| 02/12/1997 | CN1142502A Present invention relates to extraction of recombinant proteins produced by prokaryotic microorganism, especially by E. Coli |
| 02/11/1997 | US5602234 Stable antibody solution and method for preparing same |
| 02/11/1997 | US5602233 Activation and deactivation |
| 02/11/1997 | US5602096 Contacting cell with glial growth factor |
| 02/11/1997 | US5602095 Recombinant pseudomonas exotoxin with increased activity |
| 02/11/1997 | US5602034 Genetic engineering |
| 02/11/1997 | US5602033 Coccidiosis vaccine |
| 02/11/1997 | US5602031 DNA encoding molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a liver stage antigen produced by p. falciparum in hepatocytes and compositions containing them |
| 02/11/1997 | US5602025 Growth in serum-free media |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5602010 DNA encoding equine-gamma interferon and recombinant production of equine IFN-γ polypeptides |
| 02/11/1997 | US5602008 Genetic engineering |
| 02/11/1997 | US5602007 Recombinant DNA molecules |
| 02/11/1997 | US5602006 Heteropolymeric protein production methods |
| 02/11/1997 | US5602002 Chemical hydrolysis of partial hydrolysates obtained by enzymatic decomposition, in aqueous conditions in presence of alkaline-earth oxides or hydroxides, of protein raw materils containing chromium |
| 02/11/1997 | US5601989 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 02/11/1997 | US5601973 Polypeptides for diagnostic identifying specific antibodies |
| 02/11/1997 | US5601831 Vaccines for nontypable Haemophilus influenzae |
| 02/11/1997 | US5601827 Replacing or deleting certain codons of naturally-occuring diphtheria toxin |
| 02/11/1997 | US5601822 γ, δ T cell receptor and methods for detection |
| 02/11/1997 | US5601821 Histamine releasing peptide |
| 02/11/1997 | CA1338901C Recombinant dna sequences, vectors containing them and methods for the use thereof |
| 02/11/1997 | CA1338900C Escherichia coli plasmid vector with lipoprotein promoter and modified shine-dalgarno sequence |
| 02/06/1997 | WO1997004315A1 Protein p5, a serum marker for brain damage |
| 02/06/1997 | WO1997004312A1 Compounds and methods related to parathyroid hormone-like protein |
| 02/06/1997 | WO1997004122A1 Production of secreted foreign polypeptides in plant cell culture |
| 02/06/1997 | WO1997004109A1 α-β C4BP-TYPE RECOMBINANT HETEROMULTIMERIC PROTEINS |
| 02/06/1997 | WO1997004105A1 Dna polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis |
| 02/06/1997 | WO1997004099A2 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 02/06/1997 | WO1997004097A2 Human ctla-8 and uses of ctla-8-related proteins |
| 02/06/1997 | WO1997004096A1 Novel pka-binding proteins and uses thereof |
| 02/06/1997 | WO1997004095A1 Novel protein hmw human mp52 |
| 02/06/1997 | WO1997004094A1 Nucleic sequences coding for melatonin receptors, and uses thereof |
| 02/06/1997 | WO1997004092A1 P53 protein variants and therapeutical uses thereof |
| 02/06/1997 | WO1997004080A1 Novel protein and monoclonal antibody specific thereto |
| 02/06/1997 | WO1997004005A2 Cyclosporin derivatives with anti-hiv effect |
| 02/06/1997 | WO1997003999A1 Mutant s182 genes |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003696A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/06/1997 | WO1997003695A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1996040766A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 02/06/1997 | CA2227882A1 Protein p5, a serum marker for brain damage |
| 02/06/1997 | CA2227554A1 Nucleic sequences coding for melatonin receptors, and uses thereof |